Xymogen, Orlando, FL, has announced an exclusive partnership with Acasti Pharma, Québec, Canada, the biopharmaceutical company with whom they will launch the distribution of LipiChol540, a physician-prescribed medical food to manage omega 3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of Xymogen. LipiChol540 is the only medical krill oil product in the world. It is pharmaceutically formulated to provide a stronger dosage and lower pill burden, compared to popular fish oil supplements, without the typical unpleasant taste or burping side effects.